Monte Rosa Therapeutics Ratios (2020-2026) | GLUE

Ratios Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Profitability
EBT Margin (Quarter)
-2,996.71%-640.21%-258.12%25.72%56.17%-7.91%-20.17%-1,058.25%-1,033.74%
EBIT Margin (Quarter)
-3,284.49%-695.25%-287.84%21.44%51.85%-11.09%-21.98%-1,787.67%-1,163.58%
EBITDA Margin (Quarter)
-3,284.49%-695.25%-287.84%21.44%51.85%-11.09%-21.98%-1,787.67%-1,163.58%
Operating Margin (Quarter)
-3,284.49%-695.25%-287.84%21.44%51.85%-11.09%-21.98%-1,787.67%-1,163.58%
Net Margin (Quarter)
-3,006.11%-645.58%-258.89%50.68%55.20%-8.77%-18.05%-1,060.37%-1,036.07%
FCF Margin (Quarter)
-3,679.32%-643.02%-232.13%218.77%-53.92%-26.89%68.85%-1,536.28%-932.67%
Efficiency
Assets Average (Quarter)
376.50M375.19M356.17M355.53M361.33M350.00M325.71M293.82M265.36M277.93M285.25M305.43M329.60M376.91M415.97M376.39M409.71M454.25M592.54M
Asset Utilization Ratio (Quarter)
0.000.020.050.200.380.780.370.640.01
Leverage & Solvency
Interest Coverage Ratio (Quarter)
-0.21-0.24-1.32-0.60-0.92-0.39-0.98-0.47-0.51-0.52-0.64-0.52-1.56-1.331.145.98-0.27-2.08-0.43-0.41
Times Interest Earned (Quarter)
-0.21-0.24-1.32-0.60-0.92-0.39-0.98-0.47-0.51-0.52-0.64-0.52-1.56-1.331.145.98-0.27-2.08-0.43-0.41
Valuation
Enterprise Value (Quarter)
-357.06M-367.03M-346.07M-138.31M-103.66M-113.35M-55.87M-52.81M-47.03M-59.05M-128.10M-99.75M-108.85M-125.58M-380.96M-78.53M-300.86M-401.63M-129.88M-678.09M
Return Ratios
Return on Sales (Quarter)
-0.30%-0.06%-0.03%0.01%0.01%0.00%0.00%-0.11%-0.10%
Return on Capital Employed (Quarter)
-16.89%-20.33%-24.93%-27.82%-30.42%-34.64%-40.09%-48.17%-58.06%-61.95%-59.03%-52.99%-44.79%-36.88%-0.60%4.47%2.44%-13.90%-28.43%
Return on Assets (Quarter)
-0.01%-0.01%-0.01%-0.01%0.00%0.00%0.00%0.00%-0.01%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%